Arielle Elkrief

21PUBLICATIONS
244CO-AUTHORS
Tumour immunologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 08, 2026
Diet-microbiome synergy underlies obesity-associated immunotherapy efficacy.

|Jun 25, 2026
Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling.

|Jun 17, 2026
Clinicogenomic analysis of <i>EGFR</i>-mutant lung tumors identifies Rb pathway inactivation as a hallmark of squamous transformation.

|May 18, 2026
Clinical outcomes and predictors of response to PD-(L)1 blockade in patients with NSCLC without actionable genomic alterations who never used tobacco.

|Jan 28, 2026
Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial.

Sreya Duttagupta, Meriem Messaoudene, Sebastian Hunter

|Oct 20, 2025
p53 Drives Lung Cancer Regression through a TSC2/TFEB-dependent Senescence Program.

Mengxiong Wang, Kathryn T Bieging-Rolett, Alyssa M Kaiser

Pageof 4

Frequent Collaborators

9 joint publications

Marc Ladanyi

8 joint publications

Adam Schoenfeld

7 joint publications

Biagio Ricciuti

7 joint publications

Joao V Alessi